201 related articles for article (PubMed ID: 21573709)
1. Effects of Clostridium perfringens enterotoxin via claudin-4 on normal human pancreatic duct epithelial cells and cancer cells.
Yamaguchi H; Kojima T; Ito T; Kyuno D; Kimura Y; Imamura M; Hirata K; Sawada N
Cell Mol Biol Lett; 2011 Sep; 16(3):385-97. PubMed ID: 21573709
[TBL] [Abstract][Full Text] [Related]
2. Regulation of tight junctions in human normal pancreatic duct epithelial cells and cancer cells.
Kojima T; Sawada N
Ann N Y Acad Sci; 2012 Jun; 1257():85-92. PubMed ID: 22671593
[TBL] [Abstract][Full Text] [Related]
3. Transcriptional regulation of claudin-18 via specific protein kinase C signaling pathways and modification of DNA methylation in human pancreatic cancer cells.
Ito T; Kojima T; Yamaguchi H; Kyuno D; Kimura Y; Imamura M; Takasawa A; Murata M; Tanaka S; Hirata K; Sawada N
J Cell Biochem; 2011 Jul; 112(7):1761-72. PubMed ID: 21381080
[TBL] [Abstract][Full Text] [Related]
4. Targeting claudin-4 in human pancreatic cancer.
Kojima T; Kyuno D; Sawada N
Expert Opin Ther Targets; 2012 Sep; 16(9):881-7. PubMed ID: 22800288
[TBL] [Abstract][Full Text] [Related]
5. Transcriptional control of tight junction proteins via a protein kinase C signal pathway in human telomerase reverse transcriptase-transfected human pancreatic duct epithelial cells.
Yamaguchi H; Kojima T; Ito T; Kimura Y; Imamura M; Son S; Koizumi J; Murata M; Nagayama M; Nobuoka T; Tanaka S; Hirata K; Sawada N
Am J Pathol; 2010 Aug; 177(2):698-712. PubMed ID: 20566751
[TBL] [Abstract][Full Text] [Related]
6. Protein kinase Cα inhibitor enhances the sensitivity of human pancreatic cancer HPAC cells to Clostridium perfringens enterotoxin via claudin-4.
Kyuno D; Kojima T; Ito T; Yamaguchi H; Tsujiwaki M; Takasawa A; Murata M; Tanaka S; Hirata K; Sawada N
Cell Tissue Res; 2011 Dec; 346(3):369-81. PubMed ID: 22160590
[TBL] [Abstract][Full Text] [Related]
7. Clostridium perfringens enterotoxin fragment removes specific claudins from tight junction strands: Evidence for direct involvement of claudins in tight junction barrier.
Sonoda N; Furuse M; Sasaki H; Yonemura S; Katahira J; Horiguchi Y; Tsukita S
J Cell Biol; 1999 Oct; 147(1):195-204. PubMed ID: 10508866
[TBL] [Abstract][Full Text] [Related]
8. Claudin-4: a new target for pancreatic cancer treatment using Clostridium perfringens enterotoxin.
Michl P; Buchholz M; Rolke M; Kunsch S; Löhr M; McClane B; Tsukita S; Leder G; Adler G; Gress TM
Gastroenterology; 2001 Sep; 121(3):678-84. PubMed ID: 11522752
[TBL] [Abstract][Full Text] [Related]
9. Claudin-4-targeted therapy using Clostridium perfringens enterotoxin for prostate cancer.
Maeda T; Murata M; Chiba H; Takasawa A; Tanaka S; Kojima T; Masumori N; Tsukamoto T; Sawada N
Prostate; 2012 Mar; 72(4):351-60. PubMed ID: 21656836
[TBL] [Abstract][Full Text] [Related]
10. Targeting claudin-overexpressing thyroid and lung cancer by modified Clostridium perfringens enterotoxin.
Piontek A; Eichner M; Zwanziger D; Beier LS; Protze J; Walther W; Theurer S; Schmid KW; Führer-Sakel D; Piontek J; Krause G
Mol Oncol; 2020 Feb; 14(2):261-276. PubMed ID: 31825142
[TBL] [Abstract][Full Text] [Related]
11. Clostridium perfringens enterotoxin as a potential drug for intravesical treatment of bladder cancer.
Gabig TG; Waltzer WC; Whyard T; Romanov V
Biochem Biophys Res Commun; 2016 Sep; 478(2):887-92. PubMed ID: 27520378
[TBL] [Abstract][Full Text] [Related]
12. Downregulation of tight junction-associated MARVEL protein marvelD3 during epithelial-mesenchymal transition in human pancreatic cancer cells.
Kojima T; Takasawa A; Kyuno D; Ito T; Yamaguchi H; Hirata K; Tsujiwaki M; Murata M; Tanaka S; Sawada N
Exp Cell Res; 2011 Oct; 317(16):2288-98. PubMed ID: 21763689
[TBL] [Abstract][Full Text] [Related]
13. Regulation of tight junctions by sex hormones in normal human endometrial epithelial cells and uterus cancer cell line Sawano.
Someya M; Kojima T; Ogawa M; Ninomiya T; Nomura K; Takasawa A; Murata M; Tanaka S; Saito T; Sawada N
Cell Tissue Res; 2013 Nov; 354(2):481-94. PubMed ID: 23820735
[TBL] [Abstract][Full Text] [Related]
14. Cytotoxicity of Clostridium perfringens enterotoxin depends on the conditions of claudin-4 in ovarian carcinoma cells.
Tanaka S; Aoyama T; Ogawa M; Takasawa A; Murata M; Osanai M; Saito T; Sawada N
Exp Cell Res; 2018 Oct; 371(1):278-286. PubMed ID: 30142326
[TBL] [Abstract][Full Text] [Related]
15. Protein kinase Cα inhibitor protects against downregulation of claudin-1 during epithelial-mesenchymal transition of pancreatic cancer.
Kyuno D; Kojima T; Yamaguchi H; Ito T; Kimura Y; Imamura M; Takasawa A; Murata M; Tanaka S; Hirata K; Sawada N
Carcinogenesis; 2013 Jun; 34(6):1232-43. PubMed ID: 23389293
[TBL] [Abstract][Full Text] [Related]
16. Claudin-4 binder C-CPE 194 enhances effects of anticancer agents on pancreatic cancer cell lines via a MAPK pathway.
Kono T; Kondoh M; Kyuno D; Ito T; Kimura Y; Imamura M; Kohno T; Konno T; Furuhata T; Sawada N; Hirata K; Kojima T
Pharmacol Res Perspect; 2015 Dec; 3(6):e00196. PubMed ID: 27022469
[TBL] [Abstract][Full Text] [Related]
17. Eradication of chemotherapy-resistant CD44+ human ovarian cancer stem cells in mice by intraperitoneal administration of Clostridium perfringens enterotoxin.
Casagrande F; Cocco E; Bellone S; Richter CE; Bellone M; Todeschini P; Siegel E; Varughese J; Arin-Silasi D; Azodi M; Rutherford TJ; Pecorelli S; Schwartz PE; Santin AD
Cancer; 2011 Dec; 117(24):5519-28. PubMed ID: 21692061
[TBL] [Abstract][Full Text] [Related]
18. Rapid eradication of colon carcinoma by Clostridium perfringens Enterotoxin suicidal gene therapy.
Pahle J; Menzel L; Niesler N; Kobelt D; Aumann J; Rivera M; Walther W
BMC Cancer; 2017 Feb; 17(1):129. PubMed ID: 28193196
[TBL] [Abstract][Full Text] [Related]
19. Claudin-binder C-CPE mutants enhance permeability of insulin across human nasal epithelial cells.
Kojima T; Kondoh M; Keira T; Takano KI; Kakuki T; Kaneko Y; Miyata R; Nomura K; Obata K; Kohno T; Konno T; Sawada N; Himi T
Drug Deliv; 2016 Oct; 23(8):2703-2710. PubMed ID: 26036653
[TBL] [Abstract][Full Text] [Related]
20. Clostridium perfringens enterotoxin carboxy-terminal fragment is a novel tumor-homing peptide for human ovarian cancer.
Cocco E; Casagrande F; Bellone S; Richter CE; Bellone M; Todeschini P; Holmberg JC; Fu HH; Montagna MK; Mor G; Schwartz PE; Arin-Silasi D; Azoudi M; Rutherford TJ; Abu-Khalaf M; Pecorelli S; Santin AD
BMC Cancer; 2010 Jul; 10():349. PubMed ID: 20598131
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
